Monday, December 23

Tag: research

The Covid Vaccine Windfall Turns for Pfizer and Moderna
19Nov By adminNo Comments
World

The Covid Vaccine Windfall Turns for Pfizer and Moderna

Updated Nov. 19, 2023 3:03 pm ETThe U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a creature from the Black Lagoon. Public-health officials indicated we’d need another updated booster. Share prices in Pfizer and Moderna surged. By month’s end, Pfizer’s stock-market value had surpassed $300 billion, up 50% from the start of the pandemic. Moderna’s shares had soared by more than 1,000% over the same period. In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Health Care Roundup: Market Talk
17Nov By adminNo Comments
World

Health Care Roundup: Market Talk

Updated Nov. 17, 2023 12:29 pm ETThe latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0846 ET – Twist Bioscience is feeling optimistic about the year ahead after orders picked up and revenue exceeded analyst expectations in its F4Q, which ended Sept. 30. The San Francisco-based biotech company is expecting momentum behind its SynBio product group to be bolstered by Express Genes, its new gene synthesis service, and for its next-generation sequencing business to grow as customers advance their development and commercial plans, CEO Emily Leproust says. Twist is guiding for annual revenue to rise 16% to 18%, with that same growth rate for its SynBio unit. Twist expects 19% to 20% revenue growth for its next-ge...
Read More
Cyber Experts Worry AI Could Create a World of Haves and Have-Nots
15Nov By adminNo Comments
World

Cyber Experts Worry AI Could Create a World of Haves and Have-Nots

Nov. 15, 2023 2:49 pm ET|WSJ ProNEW YORK—Cybersecurity experts said that the growing sophistication of artificial-intelligence systems could create a new poverty line for cyber, where companies that can afford to research and develop the technology end up better protected against hackers than those that cannot.Security chiefs and vendors say AI systems, and in particular generative AI, may offer significant benefits for defending against hacks. These include the ability to quickly sift through vast amounts of data to flag potential compromises, identifying vulnerabilities in products and serving as assistive research tools for analysts.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8Protect your customers and organization from cyber riskS...
Read More
Bayer Pulling Lymphoma Drug Aliqopa From U.S.
13Nov By adminNo Comments
World

Bayer Pulling Lymphoma Drug Aliqopa From U.S.

Nov. 13, 2023 10:35 am ETGerman drugs-to-crops giant Bayer is pulling Aliqopa from the U.S. after a confirmatory trial of the lymphoma drug missed its primary endpoint.Bayer on Monday said it will work with the U.S. Food and Drug Administration on a voluntary withdrawal of Aliqopa, which won accelerated approval from the agency in 2017 for adults with relapsed follicular lymphoma who have received at least two prior systemic therapies.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Novo Nordisk’s Wegovy Shows Heart Benefits Beyond Weight Loss, New Data Suggests
13Nov By adminNo Comments
World

Novo Nordisk’s Wegovy Shows Heart Benefits Beyond Weight Loss, New Data Suggests

The effectiveness of Novo Nordisk’s blockbuster obesity treatment Wegovy in reducing heart attacks and strokes could be due to more than weight loss alone, according to new clinical trial data.The surging popularity of the drug has seen the Danish pharmaceutical giant scramble to boost production as it struggles to meet demand. It has been forced to limit supply of lower-strength doses of Wegovy in the U.S. as it seeks to safeguard supplies for current patients, and has outlined plans to invest more than $6 billion to boost production capacity.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Yelp Profit Soared Following IRS Guidance on R&D Tax Deductions
10Nov By adminNo Comments
World

Yelp Profit Soared Following IRS Guidance on R&D Tax Deductions

Nov. 10, 2023 12:51 pm ETYelp’s profit rocketed more than sixfold in its latest quarter, and it wasn’t entirely due to restaurant reviews.The surge in earnings was in part the effect of a one-time tax adjustment related to deductions for research and development, following recent guidance from the Internal Revenue Service.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
This doctor wrote the book on medical debt
9Nov By adminNo Comments
Money

This doctor wrote the book on medical debt

In 2019, emergency medicine physician and historian Luke Messac was working as a medical resident. He had heard about hospitals suing their own patients over unpaid medical bills, so he decided to investigate whether the hospitals where he worked were doing the same.It turns out they were."The care I was delivering to patients was resulting in them showing up in court, or having their wages garnished, or signing up for a payment plan that they would be paying for the better part of a decade," said Messac.In this episode of "An Arm and a Leg," host Dan Weissmann speaks with Messac about his book, "Your Money or Your Life: Debt Collection in American Medicine," and how people working in health care can try to reform these practices.Host and producer of "An Arm and a Leg." Previously, Dan wa...
Read More
Meta Reports Record Sales as Ad Rebound Continues
25Oct By adminNo Comments
Technology

Meta Reports Record Sales as Ad Rebound Continues

Updated Oct. 25, 2023 5:04 pm ETFacebook parent Meta Platforms reported its largest quarterly revenue since going public more than a decade ago as demand for advertising picked up and the company continued to reap the benefits of cutting costs and developing new AI technology.Meta’s sales increased to $34.1 billion, up more than 23% compared with a year ago. That represents Meta’s third quarter in a row of rising revenue after the company saw its business shrink for most of 2022. The 23% increase is Meta’s largest year-to-year growth in revenue since the third quarter of 2021. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Lufthansa partners with Airbus and Munich airport for Power-To-Liquid fuel research – Business Traveller
23Oct By adminNo Comments
Travel

Lufthansa partners with Airbus and Munich airport for Power-To-Liquid fuel research – Business Traveller

Lufthansa has signed a Letter of Intent with organisations including Airbus and Munich airport for “a broad-based research collaboration on Power-to-Liquid (PtL) aviation fuels”. The agreement – which also involves MTU Aero Engines and the German Aerospace Center (DLR) – is intended to accelerate the technology selection, market introduction and industrial scaling of PtL aviation fuels in Germany. PtL is considered by some to be the next generation of Sustainable Aviation Fuels, using regeneratively generated electricity, water and CO2 from the atmosphere to create a syngas from which sustainable aviation fuel can be produced. Lufthansa said that the collaboration would also include the testing of pure PtL (ie: without the addition of fossil kerosene) in order to gain knowledge for the a...
Read More